Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells
Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients hold great promise for autologous cell therapies. One of the possible applications of iPSCs is to use them as a cell source for producing autologous lymphocytes for cell-based therapy against cancer. Tumor-infiltrating lym...
Saved in:
Main Authors: | Hidehito Saito, Keisuke Okita, Noemi Fusaki, Michael S. Sabel, Alfred E. Chang, Fumito Ito |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/8394960 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
by: Mélanie Saint-Jean, et al.
Published: (2018-01-01) -
Reprogramming of Mouse Calvarial Osteoblasts into Induced Pluripotent Stem Cells
by: Yinxiang Wang, et al.
Published: (2018-01-01) -
Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
by: Dilip Dey, et al.
Published: (2011-01-01) -
Metabolism Is a Key Regulator of Induced Pluripotent Stem Cell Reprogramming
by: James Spyrou, et al.
Published: (2019-01-01) -
Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming
by: Pengfei Ji, et al.
Published: (2016-01-01)